| Term 
 
        | Estrogen Formulations, Uses, MOA, ADR's |  | Definition 
 
        | Oral Transdermal Vaginal IM   HRT/OC (often w/ pregesterone)   HRT: Replace what is lacking OC: Convince body its pregnant (inhibit FSH/LH)   ADR's: Nausea/HA/↑ risk of clotting>35yo or smokers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Conjugated - Premarin Estradiol - Estrace |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Vivelle Climara Estraderm |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Medroxyprogesterone - Provera |  | 
        |  | 
        
        | Term 
 
        | Combination Estrogen/Medroxyprogesterone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Selective estrogen receptor modulators SERM's |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Bisphosphonates, MOA, PK, ADR's |  | Definition 
 
        | Alendronate - Fosamax Risendronate - Actonel Ibandronate - Boniva   Inhibits osteoclastic activity: Osteoporisis/Paget's   Poor absorption, little metabolism, 10yr 1/2 life   ADR's: Nausea, Reflux, Osteonecrosis of jaw     |  | 
        |  | 
        
        | Term 
 
        | Insulins & Onset/Duration of action |  | Definition 
 
        | Rapid Acting Short Acting Intermediate Acting Long Acting Mixtures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insulin Aspart - Novolog Insulin Lispro - Humalog |  | 
        |  | 
        
        | Term 
 
        | Short Acting - Regular Insulin |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Intermediate Acting - Isophane Insulin NPH (combined w/protamine & zinc) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Insulin glargine - Lantus |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Humulin 70/30, 50/50 (intermediate/short) Humalog 75/25 (intermediate/rapid) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Sulfonylureas "Pancreas Spankers", MOA, ADR's |  | Definition 
 
        | Glipizide - Glucotrol/Glucotrol XL Glyburide - Diabeta/Micronase Glimepiride - Amaryl   MOA: binds to beta receptors and increases insulin release   ADR's: Hypoglycemia, Drug interactions   Amaryl specific: Tachycardia, hypokalemia, interacts w/non-selective beta-blockers |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Metformin - Glucophage/Glucophage XR Glyburide/Metformin - Glucovance   MOA: ↓ gluconeogenesis, ↓ glucose absorption, ↑ insulin sensitivity, doesn't cause hypoglycemia   ADR's: Lactic acidosis, creatinine contraindication  |  | 
        |  | 
        
        | Term 
 
        | Thiazidolinediones TZD's, MOA, ADR's |  | Definition 
 
        | Pioglitazone - Actos Rosiglitazone - Avandia   MOA: PPRA gamma gene modulation, ↑ insulin sensitivity   ADR's: Swelling, liver issues (hepatotoxic), CV failure     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Repaglinide - Prandin Nateglinide - Starlinx |  | 
        |  | 
        
        | Term 
 
        | Corticosteroid Formulations |  | Definition 
 
        | Topical Injection Enemas Tabs |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prednisone Methylprednisolone >7.5mg dose >2wks requires tapering off  |  | 
        |  | 
        
        | Term 
 
        | Thyroid Hormone - Synthetic T4; PK; ADR's |  | Definition 
 
        | Levothyroxine - Synthroid/Levoxyl/Levothroid   Well absorbed, >99% protein bound, Hepatic metabolism, 7 day 1/2 life   Would indicate overdose (hyperthyroidism) |  | 
        |  | 
        
        | Term 
 
        | Diuretic Classes & MOA/Strength/ADR's |  | Definition 
 
        | Loop - Inhibit Na/K/Cl Cotransporter @ thick ascending loop; MOST POTENT; innefective in renal failure;  Hypokalemia/Dehydration/Hyponatremia/Toxicity w/ACE   Thiazide - Inhibits Na/Cl Cotransporter at DCT; Mild; Hypokalemia/Hypercalcemia   K Sparing - Antagonize effects of aldosterone @ cortical CD / late DCT; Mild; Hyperkalemia/Gynomastia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Furosemide - Lasix Bumetanide - Bumex Torsemide - Demedex Ethacrinic acid |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hydroclorothiazide HCTZ Chlorthiladone Metolazone - Zaroxolyn |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Spironolactone Triamterene |  | 
        |  | 
        
        | Term 
 
        | Impotence Agents & Duration of Action |  | Definition 
 
        | Sildenafil - Viagra; 4hrs Vardenafil - Levitra; 4-6hrs Tadalafil - Cialis; 36hrs |  | 
        |  | 
        
        | Term 
 
        | BPH Agents, specificity, ADR |  | Definition 
 
        | Prazosin - Minipress; worst for hypotension Terazosin - Hytrin Doxazosin - Cardura Tamsulosin - Flowmax; Alpha 1a specific   ADR's: Hypotension, Fatigue, Dizziness, Asthenia; minimized by slow titration/QHS dosing |  | 
        |  | 
        
        | Term 
 
        | Urinary Anticholinergics, MOA, ADR |  | Definition 
 
        | Oxybtynin - Ditropan Tolterodine - Detrol *highly specific* Oxytrol patch   M3 Specific Trosplum - Sanctura Fesoteridine - Toviaz Darifenacin - Enablex Solifenacin - Vesicare   MOA: Bind to muscarinic receptor on SM of bladder ADR's: Can't See/Pee/Spit/Shit, blurry vision, impaired cognition, dizziness, fatigue, dyspepsia |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Allopurinol - Xanthine oxidase inhibitor = ↓ Uric Acid Colchicine - ↓ lactic acid production by leukocytes/↓ inflammatory respones to crystals     |  | 
        |  | 
        
        | Term 
 
        | Difference b/w: Mono, Bi, Triphasic OC |  | Definition 
 
        | Monophasic - Fixed dose of estrogen/progesterone throughout cycle   Biphasic - Estrogen stays the same for first 21 days; Progesterone lower 1st half/higher 2nd half   Triphasic - Estrogen stays the same; Progesterone changes through cycle |  | 
        |  | 
        
        | Term 
 
        | Beta 2 Agonists, MOA, Length of action, ADR's |  | Definition 
 
        | Albuterol Aerosol - Short Acting "rescue" Salmeterol - Long Acting "lipophilic"   MOA: B2 agonist = bronchodilation *Most common Tx for asthma*   ADR's: Tachycardia, hypokalemia, interactions w/non-selective Beta-blockers >1 canister/mo = overuse |  | 
        |  | 
        
        | Term 
 
        | Pulmonary Corticosteroids, MOA, ADR's |  | Definition 
 
        | Budesonide - Pulmicort Fluticasone - Flovent   MOA: ↓ cytokines, ↓ inflammation/mucous production   ADR's: HA, throat itch, wheezing, thrush |  | 
        |  | 
        
        | Term 
 
        | Inhaled Anticholenergics, Length of action, MOA |  | Definition 
 
        | Ipatropium - Atrovent; Short acting QID Tiotropium - Spiriva; Long acting QD   MOA: competitively inhibit Ach @ muscarinic receptors in airway = ↓ constriction/mucus   Combo Meds Ipatropium/Albuterol - Combivent Salmeterol/Fluticasone - Advair   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st Gen: Benadryl - 4-6hrs   2nd Gen - 12-24hrs Cetirizine - Zyrtec Levocertizine - Xyzal Fexofenadine - Allegra Desloratidine - Clarinex   Misc: Olopatadine - Patanol (for watery eyes)   MOA: Antagonist to H1 receptors 1st Gen - central & peripheral 2nd Gen - peripheral (less ADR's)     |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Triamcinolone Acetonide - Nasacort AQ Budesonide - Rhinocort Aqua Fluticasone - Flonase Mometasone - Nasonex   MOA: Same as inhaled steroid |  | 
        |  | 
        
        | Term 
 
        | Leukotriene antagonist, MOA |  | Definition 
 
        | Montelukast - Singulair   MOA: Bind to LTD4/LTE4 receptors |  | 
        |  | 
        
        | Term 
 
        | H2 Antagonists, MOA, Potency |  | Definition 
 
        | Cimetidine - Tagamet Ranitidine - Zantac Famotidine - Pepcid   MOA: Block H2 receptors on parietal cells and prevent acid production   Potency: 60-70% of acid reduction |  | 
        |  | 
        
        | Term 
 
        | Proton Pump Inhibitors, MOA, Potency |  | Definition 
 
        | Omeprazole - Prilosec Esemeprazole - Nexium Rabeprazole - Aciphex Pantoprazole - Protonix Lansoprazole - Prevacid   MOA: Prodrugs that are activated by acid transport then bind covalently to H/K ATPase enzymes   Potency: 90-98% acid reduction *↓ availability w/ food....Take on empty stomach* |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ondansetron - Zofran: 5-HT3 receptor antagonist   Prochlorperazine - Compazine Promethazine - Phenergan: CTZ inhibitor of DA/Cholenergic transmission & ↓ gastric irritants   |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sucralfate - Carafate   MOA: Creates a physical barrier over ulcers & stimulate prostaglandin/bicarb secretion |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Exenatide - Byetta Liraglutide -  Victoza |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ciprofloxacin - Cilox Oflaxacin - Occuflox Tobramycin/Dexamethasone - Tobradex |  | 
        |  |